You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for Y-27632 dihydrochloride
Y-27632 dihydrochloride is a Y-27632 synthesized to cGMP guidelines. Suitable for use as an ancillary reagent in the further manufacturing of cell therapies.
For more information about how Y-27632 may be used, please see our protocols: Transdifferentiating Fibroblasts into Neurons, Converting Fibroblasts into Cardiomyocytes (9C Cocktail), Accelerated Induction of Cortical Neurons from hiPSCs, Human iPSC-derived Myoblasts.
Research use only Y-27632 also available.
Current Good Manufacturing Practice (cGMP) is a harmonized set of guidelines that when implemented will ensure safe, reliable, consistent and quality-assured products. The Tocris range of cGMP small molecules is manufactured following relevant sections of ICH Q7 guidelines. Our highly skilled team has full control over the cGMP process, meaning we can ensure: a quality-assured manufacturing system, batch-to-batch consistency, consistent supply, traceability from starting material to final product, and animal-free production. Find out more about the Tocris range of cGMP compounds.
Technical Data for Y-27632 dihydrochloride
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
This product is intended for research use or further manufacturing only.
Product Datasheets for Y-27632 dihydrochloride
References for Y-27632 dihydrochloride
References are publications that support the biological activity of the product.
If you know of a relevant reference for Y-27632 dihydrochloride, please let us know.
Keywords: Y-27632 dihydrochloride, Y-27632 dihydrochloride supplier, cGMP, Good, Manufacturing, Practice, Process, Selective, p160ROCK, inhibitors, inhibits, Rho-Kinase, Rho-Associated, Coiled-Coil, Kinases, ROCK, ROK, stem, cells, organoids, GMP, Small, Molecules, TB1254-GMP, Tocris Bioscience
3 Citations for Y-27632 dihydrochloride
Citations are publications that use Tocris products. Selected citations for Y-27632 dihydrochloride include:
Ma et al (2021) Generation of an iPSC line (SMCPGi001-A) from a patient with Bain type X-linked mental retardation syndrome carrying HNRNPH2 gene mutation. Stem Cell Res. 57 102571 PMID: 34763229
Guo et al (2021) Establishment of an induced pluripotent stem cell line (ZJSHi001-A) from a patient with epileptic encephalopathy carrying KCNB1 Glu330Asp mutation. Stem Cell Res. 52 102224 PMID: 33607466
Gantner et al (2020) An optimized protocol for the generation of midbrain dopamine neurons under defined conditions. STAR Protoc. 1 100065 PMID: 33111103
Do you know of a great paper that uses Y-27632 dihydrochloride from Tocris? Please let us know.
Reviews for Y-27632 dihydrochloride
There are currently no reviews for this product. Be the first to review Y-27632 dihydrochloride and earn rewards!
Have you used Y-27632 dihydrochloride?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Protocols for Y-27632 dihydrochloride
The following protocols feature additional information for the use of Y-27632 dihydrochloride (Cat. No. TB1254-GMP).
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Stem Cells Scientific Review
Written by Kirsty E. Clarke, Victoria B. Christie, Andy Whiting and Stefan A. Przyborski, this review provides an overview of the use of small molecules in the control of stem cell growth and differentiation. Key signaling pathways are highlighted, and the regulation of ES cell self-renewal and somatic cell reprogramming is discussed. Compounds available from Tocris are listed.
Stem Cell Workflow Poster
Stem cells have potential as a source of cells and tissues for research and treatment of disease. This poster summarizes some key protocols demonstrating the use of small molecules across the stem cell workflow, from reprogramming, through self-renewal, storage and differentiation to verification. Advantages of using small molecules are also highlighted.